NEW YORK, Feb 25 (Reuters) – Due to weather-related delays, U.S. regulators will need an additional five days to act on a marketing application filed by Amylin Pharmaceuticals Inc and Eli Lilly and Co for a once-weekly form of their diabetes drug Byetta, the drugmakers said. Amylin and Lilly on Thursday said the U.S. Food and Drug Administration has set a new action date of March 12 for the …
Type 2 Diabetes
Act, Acting, Afx Uk Focus, Amylin Pharmaceuticals Inc, Byetta, Diabetes, Diabetes Drug, Eli Lilly, Eli Lilly And Co, Fda, Fda Action, Food And Drug, Food And Drug Administration, Interactive Investor, Marketing, Regulators, Reuters, Weather Delays
Novo Nordisk, announced that their drug, liraglutide, which will carry the trade name Victoza, has been approved by the FDA for use in the United States for the treatment of Diabetes Type II.
Type 2 Diabetes
Alzheimer Disease, Alzheimer S Disease, Diabetes, Diabetes Drug, Diabetes Type Ii, Drug Help, Fda, Liraglutide, Novo Nordisk, Scott Mendelson, Treatment Of Diabetes, United States
While shares of Novo Nordisk rose 3.3 percent Tuesday on the news that the FDA had approved its once-daily injectable glucagon-like peptide-1 (GLP-1) receptor agonist Victoza (liraglutide) for Type II diabetes, it was competitors Amylin Pharmaceuticals Inc. and Alkermes Inc. whose stock benefitted the most, surging 9 percent and 7.2 percent, respectively.
Type 2 Diabetes
Alkermes Inc, Amylin Pharmaceuticals Inc, Benefit From, Bioworld, Diabetes, Fda, Fda Approved, Glucagon, Liraglutide, Novo Nordisk, Peptide, Receptor Agonist, Rose, Shares, Stock, Type Ii Diabetes
Pharmaceutical company Novo Nordisk can look forward to billions in additional sales over the next few years, after its Victoza diabetes medicine has been approved by the US Food and Drug Administration (FDA).
Type 2 Diabetes
Billions, Copenhagen Post, Diabetes, Diabetes Medicine, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Medicine, Novo Nordisk, Pharmaceutical Company, Us Food And Drug Administration
Article by Peter Jamison.
Many hair loss products claim to have FDA approval, but what that usually means is that one of the key ingredients, Minoxidil, has been approved by the FDA for treating hair loss. Minoxidil is highly regarded as an ingredient in hair loss products although was developed originally for treating high blood pressure. Given the reputation of Minoxidil, it is a good indicator for choosing a hair loss product and given that it comes with FDA approval.
Type 2 Diabetes
Fda, Fda Approval, Hair Loss Product, Hair Loss Products, Hair Product, Hair Products, High Blood Pressure, Jamison, Minoxidil, Reputation
